ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,751.13
0.97%
US Tech 100
19,549.60
1.38%
Dow Jones
42,080.37
0.30%
Brent Oil
77.365
0.03%
Bitcoin
62,368.91
0.38%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Protara Therapeutics Inc (TARA) Quote

Protara Therapeutics Inc

Protara Therapeutics Inc (TARA)

NASDAQ
1.74
-0.02
(-1.14%)
Closed October 09 4:00PM
Delayed by 15 minutes
1.73
-0.01
(-0.57%)
After Hours: 7:59PM
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
1.74
Bid
1.68
Ask
7.00
Volume
53,093
1.71 Day's Range 1.84
1.04 52 Week Range 5.24
Market Cap
35.896M
Previous Close
1.76
Open
1.765
Last Trade
14
@
1.7116
Last Trade Time
Financial Volume
$ 92,963
VWAP
1.7509
Average Volume (3m)
151,546
Shares Outstanding
20,629,772
Dividend Yield
-
PE Ratio
-0.43
Earnings Per Share (EPS)
-1.96
Revenue
-
Net Profit
-40.42M

About Protara Therapeutics Inc

Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with rare and specialty diseases. The Protara team prioritizes creativity, diverse perspectives and tenacity to expedite our goal of bringing life-changing therapies to people with limited treatmen... Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with rare and specialty diseases. The Protara team prioritizes creativity, diverse perspectives and tenacity to expedite our goal of bringing life-changing therapies to people with limited treatment options. The company discovers, develops, and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD). Show more

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
protaratx.com
Headquarters
Wilmington, Delaware, USA
Founded
-
Protara Therapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker TARA. The last closing price for Protara Therapeutics was $1.76. Over the last year, Protara Therapeutics shares have traded in a share price range of $ 1.04 to $ 5.24.

Protara Therapeutics currently has 20,629,772 shares outstanding. The market capitalization of Protara Therapeutics is $36.31 million. Protara Therapeutics has a price to earnings ratio (PE ratio) of -0.43.

Ask ADVFN Intelligence (AI)

TARA Latest News

More News

Form 4 - Statement of changes in beneficial ownership of securities

September 12 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

September 10 2024
Edgar (US Regulatory)

Protara Therapeutics Announces Completion of First Cohort in Phase 2 STARBORN-1 Trial of TARA-002 in Pediatric Patients with Lymphatic Malformations

TARA-002 demonstrated compelling efficacy and was generally well-tolerated Enrollment in additional cohorts underway with initial results expected in 1H’25 NEW YORK, Sept. 09, 2024 (GLOBE...

September 09 2024
GlobeNewswire Inc.

Protara Therapeutics Announces Results from THRIVE-1, a Prospective Observational Study Evaluating the Prevalence of Choline Deficiency and Liver Injury in Patients Dependent on Parenteral Support

78% of patients dependent on parenteral support were choline deficient, with 63% of these patients demonstrating liver dysfunction, including steatosis, cholestasis, and hepatobiliary injuryIV...

September 09 2024
GlobeNewswire Inc.

Protara Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference

NEW YORK, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare...

September 03 2024
GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities

August 30 2024
Edgar (US Regulatory)

Form S-8 - Securities to be offered to employees in employee benefit plans

August 06 2024
Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

August 06 2024
Edgar (US Regulatory)

Form 8-K - Current report

August 06 2024
Edgar (US Regulatory)

Protara Therapeutics Announces Second Quarter 2024 Financial Results and Provides a Business Update

On track to report preliminary data from six-month evaluable patients in ADVANCED-2 trial of TARA-002 in NMIBC in Q4 2024 Expect to dose first patient in pivotal trial for IV Choline Chloride in...

August 06 2024
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.08-4.39560439561.821.891.731148961.77190698CS
4-0.09-4.918032786891.832.081.681499841.81832822CS
12-0.66-27.52.42.641.681515461.98639737CS
26-1.91-52.32876712333.653.871.682274122.62822211CS
520.010.5780346820811.735.241.041809082.83576909CS
156-5.02-74.26035502966.767.971.041050034.05961113CS
260-23.46-93.095238095225.267.0791.04946187.65866317CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
LASELaser Photonics Corporation
$ 7.92
(83.33%)
68.97M
TURBTurbo Energy SA
$ 2.75
(78.57%)
7.63M
OTRKOntrak Inc
$ 2.76
(51.65%)
98.32M
WWWW International Inc
$ 1.1682
(47.99%)
40.7M
PDYNPalladyne AI Corporation
$ 2.77
(47.34%)
21.37M
VINCVincerx Inc
$ 0.4109
(-41.13%)
9.73M
CETXCemtrex Inc
$ 0.90
(-34.31%)
13.73M
PEVPhoenix Motor Inc
$ 0.7011
(-33.23%)
6.37M
KXINKaixin Holdings
$ 0.1812
(-32.01%)
23.01M
SOBRSOBR Safe Inc
$ 6.88
(-31.88%)
859.16k
NVDANVIDIA Corporation
$ 132.89
(4.05%)
256.8M
AGRIAgriFORCE Growing Systems Ltd
$ 0.0586
(22.08%)
255.01M
XPONExpion360 Inc
$ 0.0301
(-11.99%)
206.24M
VERBVerb Technology Company Inc
$ 0.0425
(1.19%)
127.84M
SQQQProShares UltraPro Short QQQ
$ 7.34
(-4.43%)
127.21M

TARA Discussion

View Posts
Monksdream Monksdream 2 months ago
TARA under $3
👍️0
stocksrising stocksrising 4 months ago
For sure a brick wall @ 3ish!!
31,200 sold
Balance :2,282,159
By
Opaleye
05/21/2024

1,800 sold @ $3.0557
124,250
Manage account (2)

05/22/2024
9,300 sold @ $3.021
2,272,859 : balance

Very surprised seeing they are typically long term holders, and the future seems bright…perhaps they are reallocating to other losers they have (RVNC for one)

This is a $25+ PP prob in 2025…oh well, less overhead , some fund is buying I’m sure( prob the groups from recent offering) GLTA
👍️0
kindo kindo 4 months ago
Funny how when ever Opaleye wants out they find a buyer @ $3.00!
👍️0
stocksrising stocksrising 4 months ago
Opaleye keeps blowing out blocks a touch above $3 for whatever reason!!! Overhang a hinderance until their done selling..hopefully tomorrow at Cowan conf Jesse says some magic words concerning IV Choline Clor/FDA
👍️0
Monksdream Monksdream 4 months ago
TARA under $3
👍️0
stocksrising stocksrising 5 months ago
Protara Therapeutics to Present at the TD Cowen 5th Annual Oncology Innovation Summit
May 21, 2024
Download PDF
NEW YORK, May 21, 2024 (GLOBE NEWSWIRE) --Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced that management will participate in a virtual fireside chat at the TD Cowen 5th Annual
Oncology Innovation Summit on Tuesday, May 28,
2024 at 3:00 pm ET.
👍️0
stocksrising stocksrising 6 months ago
I believe this is for Ken Griffins own account

https://ir.protaratx.com/static-files/2cffa79d-9e22-4a12-a866-5308e96d8bad
👍️0
stocksrising stocksrising 6 months ago
--Oppenheimer Adjusts Protara
Therapeutics Price Target to $30
From $26
MT Newswires 08:44AM ET, 04/22/2024
👍️0
Monksdream Monksdream 6 months ago
Early Barchart https://www.barchart.com/stocks/performance/percent-change/advances?timeFrame=today&viewName=main&screener=overall&orderBy=percentChange&orderDir=desc
👍️0
stocksrising stocksrising 6 months ago
Almost 100% increase in share count( major dilution) …Market Cap pre offering ~$46mm and Post equals ~$75mm( todays price)…yes, better balance sheet, positive interim data..all in all good news, but Arbs will mess around for a bit until Funds buy again…
Jesse is pretty good steward of capital, so when q1 is reported we will see what intrinsic value is ..GLTA
👍️0
TIMGZ TIMGZ 6 months ago
sometimes have to read btw the lines*****biotech*****trial,clinical trials will taketimeand money. longtimeinvestment mosttimes
👍️0
Roadtojourney Roadtojourney 6 months ago
Why would it go red even with all the good news??
👍️0
Monksdream Monksdream 6 months ago
Will it grow legs after 9:30
👍️0
TIMGZ TIMGZ 6 months ago
WHY NOT AT $9
👍️0
Awl416 Awl416 6 months ago
Protara Therapeutics Announces Oversubscribed $45 Million Private Placement Financing
👍️0
dinogreeves dinogreeves 6 months ago
I know Monk, this should hit 5 before data. On another note ANV*S had their 10K today.
👍️0
Monksdream Monksdream 6 months ago
TARA under $4
👍️0
Poundthetable Poundthetable 6 months ago
Agreed everything in due time with TARA
👍️0
dinogreeves dinogreeves 6 months ago
Only a few months left for the data to be released.
👍️0
dinogreeves dinogreeves 7 months ago
I guess, I live in your head rent free now stupid peasant. Listen I just had lovely dinner and about to take a crap, going to think of you while I am taking a crap, with your mouth full open while I take a crap in it. Send whatever you want to the SEC, lets see what you got, you think they will listen to a peasant like you?
👍️0
jdcpa1 jdcpa1 7 months ago
Send the SEC your posts and your sell tickets so they can match them up.. pump and dump artist..
👍️0
dinogreeves dinogreeves 7 months ago
Save them all dumb peasant. I helped the SEC nail Alex Delarge you peasant.
👍️0
jdcpa1 jdcpa1 7 months ago
Ok saving your post for the SEC. Thanks dummy
👍️ 1 💎 1 💯 1
dinogreeves dinogreeves 7 months ago
This is going to hit the teens after the data read out moron. Furthermore this is a nasdaq stock not the scams you are accustomed to peasant.
👍️0
jdcpa1 jdcpa1 7 months ago
Beware folks.. there are pumpers with price predictions on here looking to close positions as they pump.. just my opinion but I think it's true.. any posts by predictors are suspect.. they are likely looking to sell..
👍️0
dinogreeves dinogreeves 7 months ago
TARA 5 to 6 dollars before data readout.
👍️0
dinogreeves dinogreeves 7 months ago
TARA 5-6 before data release, then once the data is confirmed easy will see the teens.
👍️0
Poundthetable Poundthetable 7 months ago
I been adding all the way down I like the potential here on this one fingers crossed
👍️0
dinogreeves dinogreeves 7 months ago
Hey bud, I don't have subscription anymore and refuse to pay, don't need it anymore. You got to stick out with this one and add when and if you can, news pending and they investor conference tomorrow.
👍️0
glenn1919 glenn1919 7 months ago
TARA......................................https://stockcharts.com/h-sc/ui?s=TARA&p=D&yr=0&mn=2&dy=12&id=p84071410134
👍️0
Poundthetable Poundthetable 7 months ago
Yup buying opportunities await
👍️0
dinogreeves dinogreeves 7 months ago
Wait couple of more days to add.
👍️0
dinogreeves dinogreeves 7 months ago
TARA has done exceptionally well. Only a matter of time.
👍️0
Poundthetable Poundthetable 7 months ago
Sounds good in it here 4 future growth
👍️0
dinogreeves dinogreeves 7 months ago
Data comes out positive look out above pound. Baker Brother still in the game and that is all we need to know.
👍️0
Poundthetable Poundthetable 7 months ago
Looks good Dino thanks 4 posting alert
👍️0
dinogreeves dinogreeves 7 months ago
Great action here pound. Should hit 5-6 before news.
👍️0
dinogreeves dinogreeves 8 months ago
They probably left last year, like you said for tax harvesting, it does look like it though, the stock bottoming in the low 1.05 range, which killed the stock, but it is coming back after it bottomed. Simple logic tells me, they have 300 million dollar shelf offering right now in the pipe line and there is no way they can do it here, so I think they have colluded with the market makers to drive the price higher, 5-6 dollars before news or even higher, no one knows their trick except for themselves, it would not make sense to sell securities in this range when the volume is anemic. Take a look at MDG*L chart, started at 5 range and shot up to 300-400 dollars in less than week, that one also has Baker Brothers in it and I believe it is also bladder and Liver cancer issues. Bottom line, if these ticker has the science, it will do wonders. 4 billion market cap vs 40 million market cap, so I say easily by June we can get to double digits.
👍️0
stocksrising stocksrising 8 months ago
Maybe Just year end for tax harvesting ( if they can even benefit ) or YE portfolio shuffling….they were probably leaning it all the way down to $1.5 where I picked up a bunch ( sold some too early last week @ $3.55 ( can’t argue with taken a profit) …still my largest position and will hold until we get double digits ! Jesse was at those 2 conferences, plus the Bakers ( like you said, and totally agree) helps…
Data readouts coming soon ( prob by May)
👍️0
dinogreeves dinogreeves 8 months ago
Looks like they sold. Orbimed is not as important as Baker Brothers to me, but I am curious though why Orbimed sold, we won't know until the results come out.
👍️0
stocksrising stocksrising 8 months ago
OrbiMed filed 13g/a but can’t tell if they added or sold??
👍️0
dinogreeves dinogreeves 8 months ago
TARA will see the teens fairly soon.
👍️ 2
dinogreeves dinogreeves 8 months ago
TARA moving nicely, should be around $5.00 before the results.
👍️0
stocksrising stocksrising 8 months ago
Maybe we get a bump from Conf’s:

Protara Therapeutics to Participate in Upcoming Investor Conferences
GlobeNewswire 07:30AM ET, 01/31/2024
NEW YORK, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced that management will participate in the following investor conferences:
• Guggenheim Healthcare Talks 6th
Annual Biotechnology Conference. A fireside chat will take place on Wednesday, February 7, 2024 at
10:30 am ET in New York.
• Oppenheimer 34th Annual Healthcare Life Sciences Conference. A fireside chat will take place virtually on Wednesday, February 14, 2024 at
8:40 am ET.
👍️0
stocksrising stocksrising 8 months ago
Yep, agreed ✔️
👍️0
glenn1919 glenn1919 8 months ago
TARA.................................https://stockcharts.com/h-sc/ui?s=TARA&p=W&b=5&g=0&id=p86431144783
👍️0
dinogreeves dinogreeves 8 months ago
Orbimed and Baker Brothers is all you need to know. This will hit high double digits between March and June, maybe even sooner.
👍️0
dinogreeves dinogreeves 8 months ago
This is a good one bud, still holding and waiting on that big news.
👍️0
stocksrising stocksrising 8 months ago
Looking forward hopefully to seeing some 13G/A’s, insider purchases, etc…Data readouts prob early Q2, maybe even late Q1 :)

Jesse keeps cash burn low, and RSU’s are reasonable to employees!!

Intrinsic value( after cash burn end of 2023) of perhaps $3.5-4per share( fully diluted share count about 18mm*)($50mm collecting interest income )

10k & Q prob out in March , should be good reading material

*series 1 preferred 8000sh can convert
👍️0
dinogreeves dinogreeves 10 months ago
Awesome, you can't got wrong with these prices, just buy slowly, this should organically grow its wings. Bladder cancer market is huge, companies with more advance trials are worth billions. There is a reason why Baker Brothers is here, I think at some point next year they will increase their position, once this years taxes are done, it will be a great year next year for this.
🤥 1

Your Recent History

NASDAQ
TARA
Protara Therapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved